FDA 510(k) /PMA regulatory pathways support. Perfectus Biomed can accelerate Pre-IND applications and highlight competitive advantages. 

The number of patients with orthopaedic device-related infection (ODRI) is on the rise due to an increase in orthopaedic implants. Infections relating to orthopaedic implants result in numerous problems for the healthcare industry, such as implant replacement and patient pain and discomfort, therefore increasing healthcare costs. Antimicrobial treatment of orthopaedic devices is crucial, and so improving the antimicrobial nature of medical implants will therefore improve patient well-being while reducing healthcare costs.

Perfectus Biomed can help support your research and development into microbial infection control of orthopaedic implants, from proof of concept to regulatory orthopaedic device testing.